Sultan Abdul-Jawad
Overview
Explore the profile of Sultan Abdul-Jawad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
1532
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdul-Jawad S, Beatson R, Lechmere T, Graham R, Alaguthurai T, Graham C, et al.
Haematologica
. 2022 Jan;
107(5):1181-1184.
PMID: 35045695
No abstract available.
2.
McKenzie D, Munoz-Ruiz M, Monin L, Alaguthurai T, Lechmere T, Abdul-Jawad S, et al.
Cancer Cell
. 2021 Oct;
39(11):1445-1447.
PMID: 34678151
No abstract available.
3.
Monin L, Laing A, Munoz-Ruiz M, McKenzie D, Del Molino Del Barrio I, Alaguthurai T, et al.
Lancet Oncol
. 2021 Apr;
22(6):765-778.
PMID: 33930323
Background: The efficacy and safety profiles of vaccines against SARS-CoV-2 in patients with cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (Pfizer-BioNTech) vaccine in...
4.
Abdul-Jawad S, Bau L, Alaguthurai T, Del Molino Del Barrio I, Laing A, Hayday T, et al.
Cancer Cell
. 2021 Jan;
39(2):257-275.e6.
PMID: 33476581
Given the immune system's importance for cancer surveillance and treatment, we have investigated how it may be affected by SARS-CoV-2 infection of cancer patients. Across some heterogeneity in tumor type,...
5.
Laing A, Lorenc A, Del Molino Del Barrio I, Das A, Fish M, Monin L, et al.
Nat Med
. 2020 Nov;
26(12):1951.
PMID: 33247289
A Correction to this paper has been published: https://doi.org/10.1038/s41591-020-01186-5.
6.
Laing A, Lorenc A, Del Molino Del Barrio I, Das A, Fish M, Monin L, et al.
Nat Med
. 2020 Sep;
26(10):1663.
PMID: 32908251
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
7.
Laing A, Lorenc A, Del Molino Del Barrio I, Das A, Fish M, Monin L, et al.
Nat Med
. 2020 Aug;
26(10):1623-1635.
PMID: 32807934
Improved understanding and management of COVID-19, a potentially life-threatening disease, could greatly reduce the threat posed by its etiologic agent, SARS-CoV-2. Toward this end, we have identified a core peripheral...
8.
Gupta R, Abdul-Jawad S, McCoy L, Mok H, Peppa D, Salgado M, et al.
Nature
. 2019 Mar;
568(7751):244-248.
PMID: 30836379
A cure for HIV-1 remains unattainable as only one case has been reported, a decade ago. The individual-who is known as the 'Berlin patient'-underwent two allogeneic haematopoietic stem-cell transplantation (HSCT)...
9.
Ondondo B, Murakoshi H, Clutton G, Abdul-Jawad S, Wee E, Gatanaga H, et al.
Mol Ther
. 2016 Jan;
24(4):832-42.
PMID: 26743582
An effective human immunodeficiency virus type 1 (HIV-1) vaccine is the best solution for halting the acquired immune deficiency syndrome epidemic. Here, we describe the design and preclinical immunogenicity of...
10.
Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition
Abdul-Jawad S, Ondondo B, van Hateren A, Gardner A, Elliott T, Korber B, et al.
Mol Ther
. 2015 Nov;
24(2):375-384.
PMID: 26581160
The biggest roadblock in development of effective vaccines against human immunodeficiency virus type 1 (HIV-1) is the virus genetic diversity. For T-cell vaccine, this can be tackled by focusing the...